Francesco Lanza

8.1k total citations
159 papers, 3.8k citations indexed

About

Francesco Lanza is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Francesco Lanza has authored 159 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Hematology, 42 papers in Oncology and 41 papers in Immunology. Recurrent topics in Francesco Lanza's work include Hematopoietic Stem Cell Transplantation (48 papers), Acute Myeloid Leukemia Research (45 papers) and Acute Lymphoblastic Leukemia research (26 papers). Francesco Lanza is often cited by papers focused on Hematopoietic Stem Cell Transplantation (48 papers), Acute Myeloid Leukemia Research (45 papers) and Acute Lymphoblastic Leukemia research (26 papers). Francesco Lanza collaborates with scholars based in Italy, United Kingdom and France. Francesco Lanza's co-authors include Sabrina Moretti, Mohamad Mohty, Diana Campioni, Rafael F. Duarte, Nicolaus Kröger, Andrew R. Gennery, Peter Bader, Carlo Dufour, Jakob Passweg and Helen Baldomero and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Francesco Lanza

154 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesco Lanza Italy	33	2.1k	1.0k	920	822	804	159	3.8k
Sally Arai United States	35	2.4k 1.1×	1.2k 1.2×	1.5k 1.7×	548 0.7×	1.1k 1.4×	149	4.4k
Richard Champlin United States	26	2.0k 0.9×	1.1k 1.0×	802 0.9×	951 1.2×	493 0.6×	55	3.6k
Heiwa Kanamori Japan	38	2.5k 1.2×	927 0.9×	640 0.7×	693 0.8×	473 0.6×	257	4.1k
Yoshihisa Kodera Japan	34	2.6k 1.2×	865 0.8×	1.8k 2.0×	483 0.6×	584 0.7×	143	4.1k
Damiano Rondelli United States	34	2.0k 0.9×	779 0.8×	968 1.1×	1.8k 2.1×	901 1.1×	213	4.1k
H M Lazarus United States	29	1.7k 0.8×	1.3k 1.3×	531 0.6×	1.1k 1.3×	662 0.8×	66	3.8k
Kenneth F. Bradstock Australia	37	2.3k 1.1×	1.3k 1.2×	1.3k 1.5×	682 0.8×	1.4k 1.7×	156	4.7k
Joseph P. Uberti United States	27	1.5k 0.7×	871 0.8×	803 0.9×	762 0.9×	417 0.5×	159	3.0k
RE Champlin United States	28	2.7k 1.3×	1.0k 1.0×	912 1.0×	869 1.1×	407 0.5×	50	3.4k
Luc Douay France	35	1.9k 0.9×	747 0.7×	612 0.7×	1.1k 1.3×	1.4k 1.7×	143	4.4k

Countries citing papers authored by Francesco Lanza

Since Specialization

Citations

This map shows the geographic impact of Francesco Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Lanza more than expected).

Fields of papers citing papers by Francesco Lanza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Lanza. The network helps show where Francesco Lanza may publish in the future.

Co-authorship network of co-authors of Francesco Lanza

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Lanza. A scholar is included among the top collaborators of Francesco Lanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Lanza. Francesco Lanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rondoni, Michela, Giovanni Marconi, Annalisa Nicoletti, et al.. (2025). Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype. Cancers. 17(7). 1213–1213.

Lanza, Francesco, Giuseppe Gargiulo, Paola Gargiulo, et al.. (2024). Management of iatrogenic atrial perforation caused by pacemaker electrodes: a case report. Journal of Medical Case Reports. 18(1). 524–524. 1 indexed citations

Rocchi, Serena, Beatrice Anna Zannetti, Giovanni Marconi, & Francesco Lanza. (2024). Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells. 13(10). 853–853. 3 indexed citations

Marconi, Giovanni, et al.. (2024). Novel insights and therapeutic approaches in secondary AML. Frontiers in Oncology. 14. 1400461–1400461. 2 indexed citations

Ghetti, Martina, Ivan Vannini, Maria Teresa Bochicchio, et al.. (2023). Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients. Biomedicine & Pharmacotherapy. 165. 115235–115235. 5 indexed citations

Sanz, Jaime, Myriam Labopin, Thomas Pabst, et al.. (2023). Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 58(11). 1197–1202. 1 indexed citations

Maffini, Enrico, Myriam Labopin, Dietrich W. Beelen, et al.. (2022). Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 57(10). 1556–1563. 11 indexed citations

Gottardi, Michele, Giorgia Simonetti, Alessandra Sperotto, et al.. (2021). Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin. Cancers. 13(18). 4566–4566. 12 indexed citations

Gambacorti‐Passerini, Carlo, Andrea Aroldi, Rocco Piazza, et al.. (2021). Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies. Transfusion and Apheresis Science. 60(3). 103105–103105. 3 indexed citations

10.

Fontana, Maria Chiara, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.. (2021). Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. Biomedicines. 9(4). 388–388. 9 indexed citations

11.

Lazzaro, Carlo, Luca Castagna, Francesco Lanza, et al.. (2021). Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis. Bone Marrow Transplantation. 56(8). 1876–1887. 4 indexed citations

12.

Chabannon, Christian, Ulrike Koehl, Francesco Lanza, et al.. (2019). Development of adaptive immune effector therapies in solid tumors. Annals of Oncology. 30(11). 1740–1750. 38 indexed citations

13.

Necchi, Andrea, Salvatore Lo Vullo, Simona Secondino, et al.. (2018). Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 53(6). 722–728. 1 indexed citations

14.

Gratwohl, Aloïs, Anna Sureda, Jan J. Cornelissen, et al.. (2017). Alloreactivity: the Janus-face of hematopoietic stem cell transplantation. Leukemia. 31(8). 1752–1759. 16 indexed citations

15.

Martino, Massimo, Francesco Lanza, Lorenzo Pavesi, et al.. (2015). High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry. Biology of Blood and Marrow Transplantation. 22(3). 475–481. 4 indexed citations

16.

Dabusti, Melissa, Francesco Lanza, Diana Campioni, et al.. (2003). CXCR-4 Expression on Bone Marrow CD34 ⁺ Cells Prior to Mobilization Can Predict Mobilization Adequacy in Patients with Hematologic Malignancies. Journal of Hematotherapy & Stem Cell Research. 12(4). 425–434. 14 indexed citations

17.

Lanza, Francesco, et al.. (1996). Cytofluorimetric analysis of cytokine receptors in blast cells from acute leukemia. Clinical and biological implications. Institutional Research Information System University of Ferrara (University of Ferrara). 1 indexed citations

18.

Lanza, Francesco. (1996). Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.. PubMed. 40 Suppl 1. 7–14. 8 indexed citations

19.

Lanza, Francesco, A Latorraca, Pellegrino Musto, et al.. (1991). Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: A flow cytometric and immunocytochemical study. Annals of Hematology. 63(2). 94–100. 10 indexed citations

20.

Lanza, Francesco, et al.. (1985). Hereditary myeloperoxidase deficiency syndrome. Clinical and haematological data of ten cases. Italian Journal of Medicine. 1. 45–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact